scholarly article | Q13442814 |
P50 | author | Jian-Jun Chen | Q89628907 |
P2093 | author name string | Jing Xie | |
Peng Xie | |||
Li Zeng | |||
Peng Zheng | |||
Chan-Juan Zhou | |||
P2860 | cites work | The impact of environmental factors in severe psychiatric disorders | Q21129355 |
The human urine metabolome | Q21132532 | ||
The Neurobiology of the Switch Process in Bipolar Disorder | Q22241114 | ||
Strategies to Reduce Misdiagnosis of Bipolar Depression | Q22241851 | ||
Bipolar disorder | Q22242063 | ||
Differentiating Bipolar Disorders from Major Depressive Disorders: Treatment Implications | Q22248025 | ||
The genetics of bipolar disorder | Q22251249 | ||
Innate immunity and intestinal microbiota in the development of Type 1 diabetes | Q24647312 | ||
Gut microbiota from twins discordant for obesity modulate metabolism in mice | Q29614796 | ||
The impact of the gut microbiota on human health: an integrative view | Q29617446 | ||
Central nervous system regulation of eating: Insights from human brain imaging | Q31079099 | ||
Mitochondrial protein Fus1/Tusc2 in premature aging and age-related pathologies: critical roles of calcium and energy homeostasis | Q33563545 | ||
Neurobiology of food intake in health and disease | Q33825213 | ||
Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. | Q33913309 | ||
The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice | Q34193512 | ||
The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner | Q34300369 | ||
Treatment of the depressive phase of bipolar affective disorder: a review | Q34360864 | ||
The genetics of schizophrenia and bipolar disorder: dissecting psychosis | Q34555635 | ||
Hypothalamic-pituitary-adrenal axis dysfunction and illness progression in bipolar disorder. | Q35203604 | ||
Combined Metabolomics and Proteomics Analysis of Major Depression in an Animal Model: Perturbed Energy Metabolism in the Chronic Mild Stressed Rat Cerebellum. | Q35861541 | ||
Hypothalamic-pituitary-adrenal axis and bipolar disorder. | Q36096503 | ||
Identification and validation of urinary metabolite biomarkers for major depressive disorder | Q36508139 | ||
Prospective studies of suicidal behavior in major depressive and bipolar disorders: what is the evidence for predictive risk factors? | Q36556737 | ||
Metabonomics study of essential hypertension and its chinese medicine subtypes by using gas chromatography-mass spectrometry and nuclear magnetic resonance spectroscopy | Q36682631 | ||
Identification of sex-specific urinary biomarkers for major depressive disorder by combined application of NMR- and GC-MS-based metabonomics | Q37648213 | ||
Combined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder. | Q37733240 | ||
Social cognition and the manic defense: attributions, selective attention, and self-schema in bipolar affective disorder | Q38449392 | ||
Differential urinary metabolites related with the severity of major depressive disorder | Q38669894 | ||
Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach | Q38985361 | ||
Effects of gut microbiota on the microRNA and mRNA expression in the hippocampus of mice. | Q39017815 | ||
Chronic exercise reduces hypothalamic transforming growth factor-β1 in middle-aged obese mice | Q41669849 | ||
Attentional biases toward emotional images in the different episodes of bipolar disorder: an eye-tracking study. | Q44124943 | ||
Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies. | Q45222765 | ||
Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism | Q46565524 | ||
Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder | Q46767416 | ||
Review and Meta-Analysis of Epidemiologic Studies of Adult Bipolar Disorder | Q47393233 | ||
Serum phosphatidylinositol as a biomarker for bipolar disorder liability | Q48203863 | ||
Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. | Q48649203 | ||
2,4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder. | Q50663896 | ||
Sex differences in gut microbiota in patients with major depressive disorder. | Q52665670 | ||
Integrative analysis of gut microbiota composition, host colonic gene expression and intraluminal metabolites in aging C57BL/6J mice. | Q55242726 | ||
Urinary biomarker panel for diagnosing patients with depression and anxiety disorders | Q57155162 | ||
GC-MS-based metabolomics approach to diagnose depression in hepatitis B virus-infected patients with middle or old age | Q57161916 | ||
Altered brain energy metabolism in lithium-resistant bipolar disorder detected by photic stimulated 31P-MR spectroscopy | Q73560007 | ||
Bipolar disorder | Q77549686 | ||
A multi-analytical platform approach to the metabonomic analysis of plasma from normal and Zucker (fa/fa) obese rats | Q80037913 | ||
Abnormal gut microbiota composition contributes to cognitive dysfunction in SAMP8 mice | Q89052650 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | bipolar disorder | Q131755 |
P304 | page(s) | 1008-1018 | |
P577 | publication date | 2019-02-01 | |
P1433 | published in | Aging | Q2845875 |
P1476 | title | Urinary metabolite signature in bipolar disorder patients during depressive episode | |
P478 | volume | 11 |
Q89628910 | Age-specific differential changes on gut microbiota composition in patients with major depressive disorder |
Q93167649 | Age-specific urinary metabolite signatures and functions in patients with major depressive disorder |
Q90371599 | Circulating microRNA 134 sheds light on the diagnosis of major depressive disorder |
Q90353598 | Efficacy of ginkgo biloba extract as augmentation of venlafaxine in treating post-stroke depression |
Q99403576 | Identification of Potential Metabolite Markers for Middle-Aged Patients with Post-Stroke Depression Using Urine Metabolomics |
Q64104741 | Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus |
Q93185341 | Urinary biomarkers for diagnosing poststroke depression in patients with type 2 diabetes mellitus |
Q113881439 | Verbal learning, working memory, and attention/vigilance may be candidate phenotypes of bipolar II depression in Chinese Han nationality |
Search more.